Preventing Heart Damage From Chemotherapy: OVERCOME TrialPreventing Heart Damage From Chemotherapy: OVERCOME Trial
A pilot study shows that the combination of enalapril plus carvedilol prevented left ventricular damage in cancer patients undergoing intensive chemotherapy. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Cardiology | Chemotherapy | Coreg | Enalapril | Health | Heart | Hematology | Study